Payment overview · 2025
General Payments
$32.13
2 reported records · 2 companies
Healthcare provider profile · identity verified
Robert Chris Salter, CNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · BOWDON, GA · NPI 1699789644
Verified facts
What the public records show
CMS Open Payments records show Robert Chris Salter, CNP received $32.13 in general payments during 2025 across 2 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 56.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $18.08 | 56.3% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $14.05 | 43.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $32.13 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $18.08 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $14.05 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $14.05 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 537 | 94 |
| Trazodone Hcl | Trazodone Hcl | 451 | 72 |
| Amlodipine Besylate | Amlodipine Besylate | 379 | 73 |
| Levothyroxine Sodium | Levothyroxine Sodium | 342 | 66 |
| Quetiapine Fumarate | Quetiapine Fumarate | 332 | 45 |
| Sertraline Hcl | Sertraline Hcl | 321 | 50 |
| Metformin Hcl | Metformin Hcl | 317 | 55 |
| Gabapentin | Gabapentin | 316 | 55 |
| Montelukast Sodium | Montelukast Sodium | 290 | 64 |
| Pantoprazole Sodium | Pantoprazole Sodium | 285 | 66 |
| Buspirone Hcl | Buspirone Hcl | 283 | 54 |
| Omeprazole | Omeprazole | 243 | 42 |
| Lisinopril | Lisinopril | 240 | 46 |
| Methylprednisolone | Methylprednisolone | 228 | 170 |
| Tamsulosin Hcl | Tamsulosin Hcl | 218 | 41 |
| Donepezil Hcl | Donepezil Hcl | 200 | 31 |
| Potassium Chloride | Potassium Chloride | 200 | 48 |
| Mounjaro | Tirzepatide | 191 | 26 |
| Meloxicam | Meloxicam | 188 | 41 |
| Simvastatin | Simvastatin | 186 | 30 |
| Eliquis | Apixaban | 176 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 175 | 26 |
| Losartan Potassium | Losartan Potassium | 173 | 39 |
| Hydrochlorothiazide | Hydrochlorothiazide | 172 | 32 |
| Furosemide | Furosemide | 171 | 45 |
| Metoprolol Tartrate | Metoprolol Tartrate | 164 | 33 |
| Azithromycin | Azithromycin | 159 | 124 |
| Memantine Hcl | Memantine Hcl | 144 | 29 |
| Metoprolol Succinate | Metoprolol Succinate | 139 | 27 |
| Carvedilol | Carvedilol | 131 | 22 |
| Famotidine | Famotidine | 124 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 119 | 101 |
| Risperidone | Risperidone | 119 | 16 |
| Clopidogrel | Clopidogrel Bisulfate | 114 | 25 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 111 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 106 | 16 |
| Benztropine Mesylate | Benztropine Mesylate | 105 | 13 |
| Olanzapine | Olanzapine | 99 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 98 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 90 | 23 |
| Allopurinol | Allopurinol | 89 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 87 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 85 | 39 |
| Diclofenac Sodium | Diclofenac Sodium | 83 | 28 |
| Fluoxetine Hcl | Fluoxetine Hcl | 83 | 18 |
| Levetiracetam | Levetiracetam | 80 | suppressed |
| Mirtazapine | Mirtazapine | 77 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 76 | 60 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 73 | 17 |
| Fluconazole | Fluconazole | 71 | 42 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 70 | 20 |
| Glipizide | Glipizide | 70 | 24 |
| Fenofibrate | Fenofibrate Nanocrystallized | 69 | 20 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 69 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 65 | 55 |
| Atenolol | Atenolol | 62 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 61 | 53 |
| Divalproex Sodium | Divalproex Sodium | 59 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 57 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 56 | 24 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 55 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 51 | suppressed |
| Amoxicillin | Amoxicillin | 51 | 44 |
| Oxybutynin Chloride | Oxybutynin Chloride | 51 | suppressed |
| Baclofen | Baclofen | 49 | suppressed |
| Bumetanide | Bumetanide | 46 | 11 |
| Cephalexin | Cephalexin | 45 | 37 |
| Ezetimibe | Ezetimibe | 45 | suppressed |
| Spironolactone | Spironolactone | 45 | suppressed |
| Mupirocin | Mupirocin | 44 | 32 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 43 | 11 |
| Celecoxib | Celecoxib | 42 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 42 | 11 |
| Aripiprazole | Aripiprazole | 40 | suppressed |
| Lamotrigine | Lamotrigine | 39 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 37 | 27 |
| Nystatin | Nystatin | 37 | 23 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 35 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 35 | suppressed |
| Nifedipine Er | Nifedipine | 34 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 33 | 24 |
| Ondansetron Hcl | Ondansetron Hcl | 33 | 27 |
| Paliperidone Er | Paliperidone | 32 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 32 | suppressed |
| Sucralfate | Sucralfate | 31 | suppressed |
| Jardiance | Empagliflozin | 30 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | 22 |
| Glimepiride | Glimepiride | 29 | suppressed |
| Ondansetron Odt | Ondansetron | 29 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 28 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 27 | 11 |
| Fenofibrate | Fenofibrate | 26 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 24 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 24 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 24 | suppressed |
| Valsartan | Valsartan | 24 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 23 | suppressed |
| Bupropion Xl | Bupropion Hcl | 23 | suppressed |
| Lacosamide | Lacosamide | 22 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 22 | suppressed |
| Tradjenta | Linagliptin | 22 | suppressed |
| Ranolazine Er | Ranolazine | 21 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 21 | suppressed |
| Estradiol | Estradiol | 20 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 20 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 19 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 19 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 19 | suppressed |
| Methocarbamol | Methocarbamol | 19 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 18 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 18 | suppressed |
| Ibuprofen | Ibuprofen | 18 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 18 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 17 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 16 | suppressed |
| Finasteride | Finasteride | 16 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 16 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 16 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 15 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 15 | suppressed |
| Latanoprost | Latanoprost | 15 | suppressed |
| Restasis | Cyclosporine | 15 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 15 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 14 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 14 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Ozempic | Semaglutide | 14 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 14 | suppressed |
| Synthroid | Levothyroxine Sodium | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 13 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Scopolamine | Scopolamine | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Acetazolamide | Acetazolamide | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Calcium Acetate | Calcium Acetate | 11 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 11 | suppressed |
| Prednisone | Prednisone | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 11 | suppressed |
| Tivicay | Dolutegravir Sodium | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
| Victoza 2-Pak | Liraglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $32.13 · 2 records | Otsuka America Pharmaceutical, Inc. | OTEZLA, REPATHA, REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error